India  

Remdesivir

Antiviral drug

Remdesivir    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Remdesivir: Antiviral drug
Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. As of 2020, remdesivir is being tested as a specific treatment for COVID-19, and has been authorized for emergency use in the US, India, Singapore, and approved for use in Japan for people with severe symptoms. It also received approval in the UK in May 2020, however, it was going to be rationed due to limited supply. It may shorten the time it takes to recover from the infection.

0
shares
ShareTweetSavePostSend
 

Remdesivir becomes first COVID-19 drug put forward for use in the EU [Video]

Remdesivir becomes first COVID-19 drug put forward for use in the EU

Remdesivir becomes first COVID-19 drug put forward for use in the EU

Credit: Euronews English     Duration: 00:34Published
FDA Warns Against Combining Remdesivir And Hydroxychloroquine [Video]

FDA Warns Against Combining Remdesivir And Hydroxychloroquine

The FDA has issued a warning to healthcare providers regarding two medications being tested with COVID-19. The warning cautions against administering hydroxychloroquine in combination with remdesivir...

Credit: Wochit News     Duration: 00:31Published
Coronavirus cases in India reach 2.86 lakh, ICMR says no 'community transmission' [Video]

Coronavirus cases in India reach 2.86 lakh, ICMR says no 'community transmission'

Coronavirus cases in India have crossed over 2.8 lakh. The country witnessed the highest single-day spike of 9,996 more cases in last 24 hours. In a single day, as many as 357 deaths were reported..

Credit: ANI     Duration: 01:51Published
Matt Hancock: New drug trial probably biggest step forward in Covid-19 treatment [Video]

Matt Hancock: New drug trial probably biggest step forward in Covid-19 treatment

Health Secretary Matt Hancock announced plans for a new trial of drug Remdesivir, a treatment originally developed to fight Ebola, which appears to shorten recovery time for people with Covid-19.

Credit: PA - Press Association STUDIO     Duration: 00:43Published
US Government Is Not Granting Hospitals Access To Coronavirus Medication [Video]

US Government Is Not Granting Hospitals Access To Coronavirus Medication

Remdesivir, a potential coronavirus medication was approved by the FDA last week. The emergency approval was ushered in due to the dire circumstances surrounding the coronavirus pandemic. Now, some..

Credit: Wochit News     Duration: 00:37Published

You Might Like


Six Indian firms applied to CDSCO for permission to manufacture Remdesivir drug: Govt

The CDSCO is awaiting the data and is providing complete support to these companies.
DNA - Published

Remdesivir included in 'investigational therapy' for restricted emergency use on Covid-19 patients: Health ministry


IndiaTimes - Published Also reported by •DNA

Govt adds ‘loss of smell, taste’ to its list of Covid symptoms

India has revised the protocol for clinical management of Covid-19 to include “loss of smell and taste” to the list of nine other symptoms and has also allowed use of investigational therapies like..
IndiaTimes - Published

India to soon begin domestic production of Remdesivir to fight COVID-19

Country's top drug regulator is evaluating the application submitted by four domestic pharma giants.
DNA - Published

5 firms await regulator’s nod to make Remdesivir

Despite rapidly rising Covid-19 deaths and an approval to use Remdesivir for treatment of severe cases, Indian patients are still waiting for the drug to be available in the country as companies are..
IndiaTimes - Published

Maharashtra govt to buy 10,000 vials of Remdesivir for treating COVID-19 patients

The expensive medicine will be made available to the poor and needy patients across the state.
DNA - Published

Remdesivir close to EU's initial authorisation as COVID-19 treatment

The head of the European Union's medicines agency Guido Rasi said on Monday an initial authorisation for U.S. pharmaceutical company Gilead's remdesivir as a COVID-19 treatment could be granted in..
Reuters India - Published

Corona: ‘Encouraging’ results for drug, India joins trials

India is part of the WHO ‘solidarity trials’ for the drug Remdesivir, which has shown encouraging results in serious Covid-19 patients needing enhanced oxygen and ventilator support, and will be..
IndiaTimes - Published